HomeInsightsPE

Transgene Biotek Ltd PE Ratio

Transgene Biotek Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

23.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Transgene Biotek Ltd

NSE: TRANSGENEBIOTEK

PE

-

Last updated on: Nov 22, 2024

Key Highlights

  • The P/E Ratio of Transgene Biotek Ltd is 0 as of 22 Nov 9.00 AM .
  • The P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2019 to 0 on March 2024 . This represents a CAGR of 0.0% over 6 years.
  • The Latest Trading Price of Transgene Biotek Ltd is ₹ 6.4 as of 22 Nov 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 47.6 to 43.3 in 5 years. This represents a CAGR of -1.88%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 63.4. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Transgene Biotek Ltd

No data available

Company Fundamentals for Transgene Biotek Ltd

No data available

Image

Transgene Biotek Ltd

NSE: TRANSGENEBIOTEK

Share Price

₹ 6.4

-0.10 (-1.54%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Transgene Biotek Ltd

1M

1Y

3Y

5Y

Monitoring Transgene Biotek Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20246.4
21 Nov 20246.5
19 Nov 20246.73
18 Nov 20246.79
14 Nov 20246.81
13 Nov 20247.05
12 Nov 20247.04
11 Nov 20246.8
08 Nov 20246.55
07 Nov 20246.51

SWOT Analysis Of Transgene Biotek Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Transgene Biotek Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Transgene Biotek Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Transgene Biotek Ltd

No data available

No data available

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Transgene Biotek Ltd

No data available

* All values are in crore

Historical Revenue of Transgene Biotek Ltd

No data available

* All values are in crore

Historical EBITDA of Transgene Biotek Ltd

No data available

* All values are in crore

Historical Net Profit of Transgene Biotek Ltd

No data available

* All values are in crore

Historical Dividend Payout of Transgene Biotek Ltd

No data available

* All values are in %

About Transgene Biotek Ltd

  • Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

Transgene Biotek Ltd News Hub

News

Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter

Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as...

Read more

2024-08-12 00:00:00

News

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

2024-11-05 00:00:00

News

Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter

Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024...

Read more

2024-11-12 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Transgene Biotek Ltd

What is the current PE Ratio of Transgene Biotek Ltd?

The Current PE Ratio of Transgene Biotek Ltd is 0.0 as on 22 Nov 2024.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 63.4 as on 22 Nov 2024.

What was the PE Ratio of Transgene Biotek Ltd last year?

The PE Ratio of Transgene Biotek Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Transgene Biotek Ltd indicate about its stock?

The PE Ratio of Transgene Biotek Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Transgene Biotek Ltd.

What is the PE Ratio Growth of Transgene Biotek Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Transgene Biotek Ltd grew by -% whereas, the EPS ratio grew by -133.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*